JENNIFER BENALLY: Open Payments
NPI 1720513682 · TWIN FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$209 in 10 payments from 7 companies in 2025. Trend: 2023 $266 · 2024 $596 · 2025 $209
Food & beverage: $209
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $54 |
| Neurocrine BioSciences, Inc. | 2 | $52 |
| ABBVIE INC. | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: COBENFY, INGREZZA, CAPLYTA, QULIPTA, INVEGA SUSTENNA, Auvelity, REXULTI, VRAYLAR.
Industry payments across ID — which companies pay providers there.
